According to the Virginia Department of Health, in the first half of 2021, there was an increase of 20% Statewide in emergency visits for opioid or unspecified substance overdose (excluding heroin) among Virginia residents.
are increasing the importance of environmental ethics has started to take pre...KhalidMdBahauddin
are increasing the importance of environmental ethics has started to take precedence making its global issue. as this issue do not respect National boundaries
This presentation examines the ways in which local action can achieve health equity.
Bob Gardner, Director of Policy
www.wellesleyinstitute.com
Follow us on twitter @wellesleyWI
Reducing Health Disparities: The Journey of Brightpoint HealthBrightpoint Health
Brightpoint Health's CEO and President, Paul Vitale and Chief Clinical Officer, Dr. Barbara Zeller, share Brightpoint's journey, strategies and best practices to reduce health disparities in New York City's high-need neighborhoods.
We are Worth the Investment. NSW Council for Intellectual Disability Conference 16-17 July 2015. Children, Young People and the NDIS Mary Hawkins, Branch Manager Nepean Blue Mountains Early Transition Site NDIA
Advancing Team-Based Care:Dissolving the Walls: Clinic Community ConnectionsCHC Connecticut
This final webinar of the Transforming Teams series addressed the ways innovative practices keep connected to their communities by offering non-medical services that benefit patients, linking to quality community resources, and acting as advocates in their communities for resources and programs that may be needed.
This webinar was presented Jun 2, 2016 3:00 PM Eastern Time
Mental Health Policy Briefing: Raising the Priority of California Children wi...LucilePackardFoundation
Mental health services and supports for children with special health care needs (CSHCN) must be a priority for California. This briefing will provide an overview of the mental health services to which CSHCN are entitled, highlight current state policy priorities, and share ways to engage in advocacy efforts. Speakers will be available after the briefing for questions.
Health Equity into Action: Building on Partnerships and CollaborationsWellesley Institute
This presentation offers insight on how to put health equity into action by building on partnerships and collaborations.
Bob Gardner, Director of Policy
www.wellesleyinstitute.com
Follow us on twitter @wellesleyWI
Better Healthcare Through Community and Stakeholder Engagement, 2015 Webinar ...Paul Gallant
"An enjoyable presentation, well-delivered with excellent insight into community and stakeholder engagement strategies. Terry Dyni - July 23, 2015" on the webinar version. This version is my complete slide deck from a live webinar presentation requested by the Conference Board of Canada. April, 2015. Thanks for your interest in Better Healthcare Through Community and Stakeholder Engagement.
Compliments of Paul W. Gallant, CHE, GALLANT HEALTHWORKS & Associates (GHWA), Vancouver, BC, Canada. PS See the last slide for contact details or to arrange customized training/facilitation or advice on your organizational needs.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
More Related Content
Similar to Thrives Priority Areas: Behavioral Health
are increasing the importance of environmental ethics has started to take pre...KhalidMdBahauddin
are increasing the importance of environmental ethics has started to take precedence making its global issue. as this issue do not respect National boundaries
This presentation examines the ways in which local action can achieve health equity.
Bob Gardner, Director of Policy
www.wellesleyinstitute.com
Follow us on twitter @wellesleyWI
Reducing Health Disparities: The Journey of Brightpoint HealthBrightpoint Health
Brightpoint Health's CEO and President, Paul Vitale and Chief Clinical Officer, Dr. Barbara Zeller, share Brightpoint's journey, strategies and best practices to reduce health disparities in New York City's high-need neighborhoods.
We are Worth the Investment. NSW Council for Intellectual Disability Conference 16-17 July 2015. Children, Young People and the NDIS Mary Hawkins, Branch Manager Nepean Blue Mountains Early Transition Site NDIA
Advancing Team-Based Care:Dissolving the Walls: Clinic Community ConnectionsCHC Connecticut
This final webinar of the Transforming Teams series addressed the ways innovative practices keep connected to their communities by offering non-medical services that benefit patients, linking to quality community resources, and acting as advocates in their communities for resources and programs that may be needed.
This webinar was presented Jun 2, 2016 3:00 PM Eastern Time
Mental Health Policy Briefing: Raising the Priority of California Children wi...LucilePackardFoundation
Mental health services and supports for children with special health care needs (CSHCN) must be a priority for California. This briefing will provide an overview of the mental health services to which CSHCN are entitled, highlight current state policy priorities, and share ways to engage in advocacy efforts. Speakers will be available after the briefing for questions.
Health Equity into Action: Building on Partnerships and CollaborationsWellesley Institute
This presentation offers insight on how to put health equity into action by building on partnerships and collaborations.
Bob Gardner, Director of Policy
www.wellesleyinstitute.com
Follow us on twitter @wellesleyWI
Better Healthcare Through Community and Stakeholder Engagement, 2015 Webinar ...Paul Gallant
"An enjoyable presentation, well-delivered with excellent insight into community and stakeholder engagement strategies. Terry Dyni - July 23, 2015" on the webinar version. This version is my complete slide deck from a live webinar presentation requested by the Conference Board of Canada. April, 2015. Thanks for your interest in Better Healthcare Through Community and Stakeholder Engagement.
Compliments of Paul W. Gallant, CHE, GALLANT HEALTHWORKS & Associates (GHWA), Vancouver, BC, Canada. PS See the last slide for contact details or to arrange customized training/facilitation or advice on your organizational needs.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
2. Behavioral Health
Priority Area
What is Behavioral Health?
Behavioral health includes the
emotions and behaviors that affect
your overall well-being. It generally
refers to mental health and substance
use disorders, life stressors and crises,
and stress-related physical symptoms.
Behavioral health care refers to the
prevention, diagnosis and treatment of
those conditions.
20XX presentation title 2
4. CIBH Programs
• Same Day Access Clinic – Same day appointments for
registration/intake to begin services at CIBH or to provide
linkage to resources if CIBH does not have services
individual is seeking
• Outpatient Counseling – for both mental health and
substance use
• Substance Use Groups
• Psychiatric Services for medication management
• Case Management – mental health, substance use,
intellectual and developmental disabilities
20XX presentation title 4
5. CIBH Programs
• Office Based Addiction Treatment (OBAT) - Medication
assisted therapy for treating opioid dependence
• Emergency Services – 24/7 emergency call line and
prescreening services, also assist with linkage to inpatient
hospitalization
• Forensic Services – to assist individuals enrolled in Drug
Court, individuals discharging from jail and individuals
discharging from state psychiatric hospitals with linkage to
services and discharge planning
• Assertive Community Treatment (ACT) – long-term treatment
for those with serious mental illness
20XX presentation title 5
6. CIBH Programs
• Prevention Services – provides outreach and training to the
community
• Peer Recovery Services – utilizes their lived experience to help others
in their own recovery process
• Psychosocial Rehabilitation Services – community day program
• Intellectual Disability Services – Respite resources, intermediate care
facility, supportive living program, community options group day
program, voucher program
• Infant and Toddler Connection of Chesapeake – early intervention
services
20XX presentation title 6
7. Priority Area Objective #1:
Strengthen, expand, and diversify
behavioral health prevention-
oriented programming
8. Where we’ve been
• Prevention provides a multitude of trainings/presentations that
are offered to community members, providers and city
employees.
• Prevention hosts resource tables at events, leads the CWPC,
is involved in Chesapeake Thrives Initiative, distributes rack
cards, engages in marketing and awareness strategies and
attends relevant trainings and conferences to stay abreast of
hot topics, developing problem areas and new resources
available.
• CIBH Peer Services have also been filming a "Recovery Life"
series where they discuss behavioral health and interventions
and treatment available in efforts to decrease the stigma of
behavioral health conditions
20XX presentation title 8
9. Where we’re going
• Prevention has been taking steps to get more involved in
the public school system/youth and faith-based
communities
• CIBH will be partnering with a digital platform called
Healthier 757 that will allow for free, online access to a
wide variety of informative resources targeting
prevention and treatment for behavioral health.
• CIBH was recently awarded a grant for a mobile harm
reduction unit that will be promoting community
awareness prevention, mental health, substance use
and wellness resources that are available.
20XX presentation title 9
10. Priority Area Objective #2:
Strengthen, expand and
diversify behavioral health
intervention services
11. Where we’ve been
• CIBH has multiple representatives that are part of the
Chesapeake Thrives Initiative, allowing for collaboration
with a multitude of other providers.
• CIBH provides regular updates to local providers on
services that CIBH offers to increase awareness of
intervention resources.
• CIBH also provides resources for local outside providers to
community members who come to CIBH seeking services
that CIBH does not offer.
• Prevention utilizes multiple media platforms to promote
awareness of treatment interventions available to the
community.
20XX presentation title 11
12. Where we’re going
• The mobile harm reduction unit and the partnership with
the Healthier 757 digital platform (mentioned on slide 9)
will allow for increased collaboration, awareness of
available resources and informative resources to help
decrease stigma associated with behavioral health.
• CIBH is in discussion with Virginia Health Department
and Healthy Chesapeake about potential partnerships
for the mobile harm reduction unit.
• The mobile harm reduction unit will be peer ran, allowing
for individuals with lived experience to work with
community members and help normalize and
destigmatize behavioral health and treatment available
to support recovery.
20XX presentation title 12
13. Priority Area Objective #3:
Strengthen, expand, diversify
treatment services to improve
the behavioral health and well-
being of residents
14. Where we’ve been
• CIBH offers bus passes, interpretur services, diverse staff,
sliding scale fee for uninsured individuals and some services
both in-person and virtually and assistance with Medicaid
Application process
• Expanded hours in Same Day Acccess clinic and Outpatient
Services extended with evening hours
• Case Manager staffed at We Care Resource Center several
days a week to assist with linkage to services
• Prevention services hosts resource tables at events to
promote awareness of available resources
20XX presentation title 14
15. Where we’re going
• Mobile Harm Reduction Unit will be community based
and will be able to "meet people where they are at" both
literally and figuratively
• CIBH is opening a 23-hour Crisis Receiving Center
• CIBH will be offering inductions in the OBAT program
20XX presentation title 15
17. History
• The coalition was originally two separate
coalitions – SUPAC and MHW
• CIBH Prevention recognized common goals and
combined them into one!
• Dual citizenship purpose – Thrives priority area
workgroup and CIBH Prevention funding
requirement!
20XX presentation title 17
18. • Various CIBH departments
• Faith-based community
• NAMI
• Private behavioral health
clinic
• Health Department
• Various Human Services
departments
• Optima Health
• Family in Focus
• City HR department
• FACE
• Kempsville Center
• Chesapeake Regional
• CHKD
• Chesapeake Public Schools
• Chesapeake Parks and
Recreation
• Kin and Kids
• VB Strong Center
• Chesapeake Police Department
20XX presentation title 18
Member Make-Up
19. Goals and Initiatives
• Overall Goals:
• To collaborate on common interests
• Partner for projects throughout the year
• Support each other's own initiatives
• Identify the needs of the citizens of Chesapeake and develop a
response.
• Goals specific for Spring 2024:
• Partner to host 2 conferences:
• 1 for seniors
• 1 for both youth and their families to increase attendance and provide
information to both groups at one time
• Increase membership by recruiting stakeholders from local
businesses and citizens
20XX presentation title 19
21. What you can do!
• Join the coalition
• Support the objectives by
sharing the resources we
offer
• Attend trainings and events
hosted by CIBH Prevention
Team
• Break the stigma
• Spread the word
20XX presentation title 21
Substance use groups – variety of clients – been in recovery for long time, mandated, active users, probation, etc.
OBAT = Suboxone
ACT = team of people meeting them in the community
Healthier 757 – offer things like modules, videos, quizzes, etc. To accommodate every learning style
Mobile harm reduction unit – phases – building trust, resources, rescue bags
Updates – through committees, coalitions, meetings, digital communication
Part 2: Medical partnerships for mobile harm reduction unit – STD testing and education on needle usage; Partnering with Phyllis so some days they can be at the same site.